The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Authors
Keywords
-
Journal
Cell Metabolism
Volume 35, Issue 2, Pages 253-273
Publisher
Elsevier BV
Online
2023-02-07
DOI
10.1016/j.cmet.2023.01.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study
- (2022) Chih-Yiu Tsai et al. Frontiers in Endocrinology
- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
- (2022) Thomas Karagiannis et al. DIABETOLOGIA
- GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation
- (2022) Ashok Mayendraraj et al. PEPTIDES
- Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide
- (2022) Charlotte C. van Ruiten et al. Frontiers in Endocrinology
- The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion
- (2022) Anna Pii Hjørne et al. Metabolites
- A single, high-fat meal adversely affects postprandial endothelial function: a systematic review and meta-analysis
- (2022) Juanita J Fewkes et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Revisiting ‘intensive’ blood glucose control: A causal directed acyclic graph‐guided systematic review of randomized controlled trials
- (2022) Chi‐Jung Huang et al. DIABETES OBESITY & METABOLISM
- Intestinal lipid absorption and transport in type 2 diabetes
- (2022) Bruno Vergès DIABETOLOGIA
- Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
- (2022) Julian M Yabut et al. ENDOCRINE REVIEWS
- Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension
- (2022) Trenton E. Banks et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
- (2022) Giulia Bendotti et al. PHARMACOLOGICAL RESEARCH
- Efficacy of subcutaneous semaglutide compared to placebo for weight loss in obese, non-diabetic adults: a systematic review & meta-analysis
- (2022) Naazneen Arastu et al. International Journal of Clinical Pharmacy
- Obesity-Related Chronic Kidney Disease: Principal Mechanisms and New Approaches in Nutritional Management
- (2022) Alessandra Stasi et al. Frontiers in Nutrition
- Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
- (2022) Jens Juul Holst Frontiers in Nutrition
- Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation
- (2022) Katherine N. Cahill et al. JACC-Basic to Translational Science
- Managing thrombotic risk in patients with diabetes
- (2022) A. John Camm et al. Cardiovascular Diabetology
- Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials
- (2022) Ofri Mosenzon et al. Cardiovascular Diabetology
- The role of gut-derived oxidized lipids and bacterial lipopolysaccharide in systemic inflammation and atherosclerosis
- (2022) Huan Wang et al. CURRENT OPINION IN LIPIDOLOGY
- Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis
- (2022) Xiang Li et al. DIABETES & METABOLISM
- Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents
- (2022) Caroline E. Geisler et al. DIABETES OBESITY & METABOLISM
- Activation of arcuate nucleus glucagon-like peptide-1 receptor-expressing neurons suppresses food intake
- (2022) Ishnoor Singh et al. Cell and Bioscience
- Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
- (2022) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein
- (2022) Simon Hoffman et al. Molecular Metabolism
- Postprandial changes of oxidative stress biomarkers in healthy individuals
- (2022) Fengyi Huang et al. Frontiers in Nutrition
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- (2022) Aruna Das Pradhan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- (2021) Suetonia C Palmer et al. BMJ-British Medical Journal
- Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis
- (2021) Ursula Schwab et al. EUROPEAN JOURNAL OF NUTRITION
- GLP-1 (Glucagon-Like Peptide-1) Is Physiologically Relevant for Chylomicron Secretion Beyond Its Known Pharmacological Role
- (2021) Avital Nahmias et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The effect of glucagon-like peptide-1 receptor agonists on 24-hour ambulatory blood pressure
- (2021) Dimitrios Patoulias et al. BLOOD PRESSURE MONITORING
- Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials
- (2021) Jonathan J. H. Bray et al. DIABETES OBESITY & METABOLISM
- Potential kidney protection with liraglutide and semaglutide – exploratory mediation analysis
- (2021) Johannes F. E. Mann et al. DIABETES OBESITY & METABOLISM
- Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial
- (2021) Charlotte C. van Ruiten et al. DIABETES OBESITY & METABOLISM
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
- (2021) Domenica Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeting inflammation in atherosclerosis — from experimental insights to the clinic
- (2021) Oliver Soehnlein et al. NATURE REVIEWS DRUG DISCOVERY
- Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus
- (2021) Junjie Shang et al. PeerJ
- Effect of ingesting a meal and orthostasis on the regulation of splanchnic and systemic hemodynamics and the responsiveness of cardiovascular α1-adrenoceptors
- (2021) Farid Zreik et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment
- (2021) Stefan Trapp et al. BRITISH JOURNAL OF PHARMACOLOGY
- Reappraising the role of the vagus nerve in GLP‐1‐mediated regulation of eating
- (2021) Daniel I. Brierley et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation
- (2021) Agata Hanna Bryk-Wiązania et al. Cardiovascular Diabetology
- Postprandial superior mesenteric artery blood flow is related to changes in peripheral pulse wave harmonics and heart rate: implications for wearable technology?
- (2021) Eamon Abdullah et al. JOURNAL OF APPLIED PHYSIOLOGY
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential for Gut Peptide-Based Therapy in Postprandial Hypotension
- (2021) Malcolm J. Borg et al. Nutrients
- Metabolic endotoxemia is dictated by the type of lipopolysaccharide
- (2021) Fernando F. Anhê et al. Cell Reports
- Gastrointestinal Distension by Pectin-Containing Carbonated Solution Suppresses Food Intake and Enhances Glucose Tolerance via GLP-1 Secretion and Vagal Afferent Activation
- (2021) Kento Ohbayashi et al. Frontiers in Endocrinology
- What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?
- (2021) Rune E. Kuhre et al. Frontiers in Endocrinology
- Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
- (2021) Manige Konig et al. Cardiovascular Diabetology
- Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
- (2021) Ahmed M. Shaman et al. CIRCULATION
- Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervention trials
- (2021) Jean Strelitz et al. DIABETOLOGIA
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Meta-Analysis of Randomized Controlled Trials Evaluating the Effect of Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists on Blood Pressure Levels in Patients With Type 2 Diabetes Mellitus
- (2021) Dimitrios Patoulias et al. AMERICAN JOURNAL OF CARDIOLOGY
- GLP-1 physiology informs the pharmacotherapy of obesity
- (2021) Daniel J. Drucker Molecular Metabolism
- Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions
- (2020) Marieke Sternkopf et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α
- (2020) M. Ahsan Siraj et al. JOURNAL OF CLINICAL INVESTIGATION
- The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
- (2020) Hertzel C Gerstein et al. Lancet Diabetes & Endocrinology
- Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction
- (2020) Marco Trevisan et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial
- (2020) Jie Zhang et al. Cardiovascular Diabetology
- Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes
- (2020) M. Angelyn Bethel et al. CIRCULATION
- Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
- (2020) John B. Buse et al. DIABETES CARE
- Glucose control: not just a bystander in GLP-1RA-mediated cardiovascular protection
- (2020) Irene Caruso et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- SELECT (Semaglutide effects on cardiovascular outcomes in people with overweight or obesity) rationale and design
- (2020) Donna H. Ryan et al. AMERICAN HEART JOURNAL
- Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis
- (2020) Michelle C Flynn et al. CIRCULATION RESEARCH
- Remnant lipoproteins
- (2020) Carlos A. Aguilar Salinas et al. CURRENT OPINION IN LIPIDOLOGY
- Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion
- (2020) Brandon L. Panaro et al. Molecular Metabolism
- Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
- (2020) Francis S. Willard et al. JCI Insight
- Strategies to Treat Obesity in Patients With CKD
- (2020) Kiran Chintam et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Legacy effect of intensive glucose control on major adverse cardiovascular outcome: Systematic review and meta-analyses of trials according to different scenarios
- (2020) Francesco Prattichizzo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
- (2020) Carolyn F. Deacon Nature Reviews Endocrinology
- Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities
- (2020) Pei-Hui Lin et al. Frontiers in Physiology
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
- (2020) Nordin M. J. Hanssen et al. Frontiers in Cardiovascular Medicine
- Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus
- (2020) Davide Capodanno et al. CIRCULATION
- Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
- (2020) Brent A McLean et al. ENDOCRINE REVIEWS
- Impact of glucagon response on early postprandial glucose excursions irrespective of residual β‐cell function in type 1 diabetes: A cross‐sectional study using a mixed meal tolerance test
- (2020) Ayako Ito et al. Journal of Diabetes Investigation
- Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events
- (2020) Kallirroi Kalantzi et al. Journal of the American Heart Association
- Exendin-4 induces a novel extended effect of ischemic tolerance via crosstalk with IGF-1R
- (2020) Huinan Zhang et al. BRAIN RESEARCH BULLETIN
- Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
- (2019) V. R Aroda et al. DIABETES & METABOLISM
- Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycemia in health and type 2 diabetes
- (2019) Karen L. Jones et al. DIABETES OBESITY & METABOLISM
- Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality
- (2019) Jean Strelitz et al. DIABETOLOGIA
- Protective effects of liraglutide on glomerular podocytes in obese mice by inhibiting the inflammatory factor TNF-α-mediated NF-κB and MAPK pathway
- (2019) Yongjian Ye et al. Obesity Research & Clinical Practice
- Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort
- (2019) Alexander Peikert et al. Clinical Research in Cardiology
- Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
- (2019) Faisal Rahman et al. HYPERTENSION
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protective effects of glucagon‐like peptide‐1 on cardiac remodeling by inhibiting oxidative stress through mammalian target of rapamycin complex 1/p70 ribosomal protein S6 kinase pathway in diabetes mellitus
- (2019) Dongjuan Wang et al. Journal of Diabetes Investigation
- Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin Action
- (2019) Elodie M. Varin et al. Cell Reports
- Healthy Dietary Patterns and Incidence of CKD
- (2019) Katrina E. Bach et al. Clinical Journal of the American Society of Nephrology
- Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin
- (2019) Anastasia-Stefania Alexopoulos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Atherosclerosis
- (2019) Peter Libby et al. Nature Reviews Disease Primers
- Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes
- (2019) Ruth L. Coleman et al. Cardiovascular Diabetology
- The oral glucose tolerance test-derived incremental glucose peak is associated with greater arterial stiffness and maladaptive arterial remodeling: The Maastricht Study
- (2019) Yuri D. Foreman et al. Cardiovascular Diabetology
- Postprandial Vascular Dysfunction Is Associated With Raised Blood Pressure and Adverse Left Ventricular Remodeling in Adolescent Adiposity
- (2019) Jakob A. Hauser et al. Circulation-Cardiovascular Imaging
- The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship
- (2019) Michael A. Nauck METABOLISM-CLINICAL AND EXPERIMENTAL
- Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors
- (2019) Nobuo Fuke et al. Nutrients
- Simultaneous angiotensin receptor blockade and glucagon‐like peptide‐1 receptor activation ameliorate albuminuria in obese insulin‐resistant rats
- (2019) Ruben Rodriguez et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
- (2019) Michael A Nauck et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Glucagon-like peptide-1 increased the vascular relaxation response via AMPK/Akt signaling in diabetic mice aortas
- (2019) Kumiko Taguchi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Human Postprandial Nutrient Metabolism and Low-Grade Inflammation: A Narrative Review
- (2019) Emma C.E. Meessen et al. Nutrients
- Diabetic Kidney Disease: Is There a Role for Glycemic Variability?
- (2018) Savitha Subramanian et al. Current Diabetes Reports
- Incretins and Lipid Metabolism
- (2018) Vasilis Tsimihodimos et al. CURRENT MEDICINAL CHEMISTRY
- Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
- (2018) Bo Ahrén et al. DIABETES OBESITY & METABOLISM
- A single high-fat meal provokes pathological erythrocyte remodeling and increases myeloperoxidase levels: implications for acute coronary syndrome
- (2018) Tyler W Benson et al. LABORATORY INVESTIGATION
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis
- (2018) Chengshi Wang et al. PLoS One
- Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
- (2018) Katherine R Tuttle et al. Lancet Diabetes & Endocrinology
- The Origin and Understanding of the Incretin Concept
- (2018) Jens F. Rehfeld Frontiers in Endocrinology
- Glucagon-Like Peptide-1 and its Cleavage Products are Renoprotective in Murine Diabetic Nephropathy
- (2018) Moellmann Julia et al. DIABETES
- Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus
- (2018) Rosa Bretón‐Romero et al. Journal of the American Heart Association
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETOLOGIA
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss
- (2018) Paola Simeone et al. Nutrients
- The impact of liraglutide on the JAK-STAT pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells
- (2018) Tali Zitman-Gal et al. Journal of Diabetes
- Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
- (2018) Marcel H A Muskiet et al. Lancet Diabetes & Endocrinology
- Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
- (2017) Yoon Oh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Postprandial Hyperlipidemia and Remnant Lipoproteins
- (2017) Daisaku Masuda et al. Journal of Atherosclerosis and Thrombosis
- Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
- (2017) Mohsen Mazidi et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Metabolic endotoxemia and diabetes mellitus: A systematic review
- (2017) Júnia Maria Geraldo Gomes et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis
- (2017) Shuyang Traub et al. Cell Reports
- Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis
- (2016) Patricia M. Howse et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Comprehensive assessment of the global and regional vascular responses to food ingestion in humans using novel rapid MRI
- (2016) Jakob A. Hauser et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
- (2016) Manfredi Rizzo et al. Cardiovascular Diabetology
- Glucagon and heart in type 2 diabetes: new perspectives
- (2016) Antonio Ceriello et al. Cardiovascular Diabetology
- Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis
- (2016) Alison Cameron-Vendrig et al. DIABETES
- Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men
- (2016) M. H. A. Muskiet et al. DIABETES OBESITY & METABOLISM
- Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial
- (2016) J. Skov et al. DIABETES OBESITY & METABOLISM
- Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
- (2016) Lennart Tonneijck et al. DIABETOLOGIA
- Neuroprotective Effects of rhGLP-1 in Diabetic Rats with Cerebral Ischemia/Reperfusion Injury
- (2016) Daoli Jiang et al. DRUG DEVELOPMENT RESEARCH
- Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects
- (2016) Masashi Tanaka et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Central & peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors
- (2016) Sunil Sirohi et al. PHYSIOLOGY & BEHAVIOR
- Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels
- (2016) Galia Spectre et al. THROMBOSIS RESEARCH
- Postprandial Metabolism of Macronutrients and Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions
- (2016) Miriam Jacome-Sosa et al. Advances in Nutrition
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- (2016) Lancet Diabetes & Endocrinology
- Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment
- (2016) Lin Wang et al. Scientific Reports
- In vivo evidence for chylomicrons as mediators of postprandial inflammation
- (2015) Marijke A. de Vries et al. ATHEROSCLEROSIS
- Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
- (2015) Keiichi Torimoto et al. Cardiovascular Diabetology
- Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism
- (2015) Changting Xiao et al. DIABETES
- Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
- (2015) Juraj Koska et al. DIABETES
- Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes
- (2015) Laurence G. Trahair et al. DIABETOLOGIA
- Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: A pilot study
- (2015) Susana Ravassa et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease
- (2015) Akihiro Nakamura et al. HEART AND VESSELS
- Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study
- (2015) Manfredi Rizzo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes
- (2015) Bernt Johan von Scholten et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Postprandial Hypotension Is Associated With More Rapid Gastric Emptying in Healthy Older Individuals
- (2015) Laurence G. Trahair et al. Journal of the American Medical Directors Association
- Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies
- (2015) Barbara Sottero et al. MEDICINAL RESEARCH REVIEWS
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fast food increases postprandial cardiac workload in type 2 diabetes independent of pre-exercise: A pilot study
- (2015) Siri Marte Hollekim-Strand et al. Nutrition Journal
- Prognostic Value of Flow-Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta-Analysis
- (2015) Y. Matsuzawa et al. Journal of the American Heart Association
- Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study
- (2015) Björn Eliasson et al. Lancet Diabetes & Endocrinology
- Diabetic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Disease Primers
- Intermittent High Glucose Implements Stress-Induced Senescence in Human Vascular Endothelial Cells: Role of Superoxide Production by NADPH Oxidase
- (2015) Morihiko Maeda et al. PLoS One
- Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials
- (2014) B. Ahrén et al. DIABETES OBESITY & METABOLISM
- Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment
- (2014) B. J. von Scholten et al. DIABETIC MEDICINE
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Pathway-selective Insulin Resistance and Metabolic Disease: The Importance of Nutrient Flux
- (2014) Yolanda F. Otero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia
- (2014) S. Briyal et al. NEUROSCIENCE
- Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial
- (2014) Lancet Diabetes & Endocrinology
- Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy
- (2013) Adam P. Chambers et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe−/− mice
- (2013) Mathias Burgmaier et al. ATHEROSCLEROSIS
- The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model
- (2013) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Exenatide-Induced Reduction in Energy Intake Is Associated With Increase in Hypothalamic Connectivity
- (2013) H. Schlogl et al. DIABETES CARE
- Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
- (2013) A. Ceriello et al. DIABETES CARE
- Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up
- (2013) Chaochen Wang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
- (2013) Andrew E. Hogan et al. DIABETOLOGIA
- Early postprandial glucagon surge affects postprandial glucose levels in obese and non-obese patients with type 2 diabetes
- (2013) Junji Kozawa et al. ENDOCRINE JOURNAL
- The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
- (2013) Hiroki Fujita et al. KIDNEY INTERNATIONAL
- Real-time trafficking and signaling of the glucagon-like peptide-1 receptor
- (2013) Sarah Noerklit Roed et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes
- (2012) Meg J. Jardine et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus
- (2012) Steven G. Coca et al. ARCHIVES OF INTERNAL MEDICINE
- Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation
- (2012) Daisuke Shiraishi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- GLP-1 and cardioprotection: from bench to bedside
- (2012) S. Ravassa et al. CARDIOVASCULAR RESEARCH
- Sympathoinhibitory signals from the gut and obesity-related hypertension
- (2012) Daniela M. Sartor CLINICAL AUTONOMIC RESEARCH
- GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic MaleApoE−/−Mice
- (2012) Naim Panjwani et al. ENDOCRINOLOGY
- Effects of Fibrates in Kidney Disease
- (2012) Min Jun et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus
- (2011) Marshall Elam et al. Clinical Lipidology
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Glucagon-like Peptide-1 (GLP-1), Immediately Prior to Reperfusion, Decreases Neutrophil Activation and Reduces Myocardial Infarct Size in Rodents
- (2011) B. B. Dokken et al. HORMONE AND METABOLIC RESEARCH
- Significant Increase of Apolipoprotein B48 Levels by a Standard Test Meal in Type 2 Diabetic Patients with Nephropathy
- (2011) Takeshi Yamamoto et al. Journal of Atherosclerosis and Thrombosis
- Relationship between postprandial changes in cardiac left ventricular function, glucose and insulin concentrations, gastric emptying, and satiety in healthy subjects
- (2011) Joanna Hlebowicz et al. Nutrition Journal
- Lipoprotein-specific transport of circulating lipid peroxides
- (2010) Markku Ahotupa et al. ANNALS OF MEDICINE
- Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus
- (2010) Eric A. Schwartz et al. ATHEROSCLEROSIS
- One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress
- (2010) Mathijs C. Bunck et al. ATHEROSCLEROSIS
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2010) P. L. Drury et al. DIABETOLOGIA
- Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
- (2009) Yuji Ishibashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Increase in Plasma Endotoxin Concentrations and the Expression of Toll-Like Receptors and Suppressor of Cytokine Signaling-3 in Mononuclear Cells After a High-Fat, High-Carbohydrate Meal: Implications for insulin resistance
- (2009) H. Ghanim et al. DIABETES CARE
- The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
- (2009) J. Hsieh et al. DIABETOLOGIA
- Intensive glucose control and macrovascular outcomes in type 2 diabetes
- (2009) F. M. Turnbull et al. DIABETOLOGIA
- Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
- (2009) B. E. de Galan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study: Implications for Fenofibrate
- (2008) Frank M. Sacks AMERICAN JOURNAL OF CARDIOLOGY
- Alimentary lipemia enhances procoagulatory effects of inflammation in patients with a history of acute myocardial infarction complicated by ventricular fibrillation
- (2007) Thorsten Kälsch et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started